Smell and Taste Impairments in Head and Neck Cancer Patients—A Scoping Review
Open Access
Abstract
Head and neck cancer affects millions worldwide. The risk factors are numerous, including smoking, alcohol consumption, and human papillomavirus to name a few. While improved preventative, diagnostic, and treatment methods have decreased mortality rates, the treatments (chemotherapy, radiotherapy, or surgery) often result in smell and/or taste impairments. These can impact quality of life during and after cancer treatment. A scoping review was performed to understand current research and future directions regarding smell and taste impairments in head and neck cancer patients. PRISMA guidelines were followed and Rayyan.ai was used to search and compile journal articles. Three databases, EBSCOhost, Google Scholar, and PubMed, were also searched. Search terms included smell, taste, dysgeusia, ageusia, hypogeusia, parosmia, anosmia, hyposmia, dysosmia, and head and neck cancer. A total of 1580 articles were found through Rayyan.ai and 8022 were found through the three databases, which were manually screened. Articles assessing patients with a different malignancy, benign tumors, pediatric populations, animal studies, abstracts, and review articles were excluded. A total of 47 articles were found using this strategy. Of those we identified, 37 articles discussed taste impairments, 12 articles discussed smell impairments, and 3 articles discussed treatments for smell and/or taste impairments. All 37 articles concluded that there was some taste alteration in head and neck cancer patients due to their treatment. However, the specific taste qualities (sweet, sour, salty, or bitter) that were impaired, whether taste function returned to baseline, and which treatments led to impairments varied. For the 12 studies that assessed smell impairments, the results also varied. Some studies found significant objective impairments in smell while others found no significant impairment. Zinc sulfate was not found to be an effective treatment option for taste impairments; however, a liposomal spray showed some potential. Future studies should aim to understand which treatments and types of head and neck cancer lead to chemosensory impairments, whether chemosensory alterations negatively impact a patient’s nutritional status, and treatments or preventative measures for smell and taste changes.Keywords
Funding Information
- NIH-NIDCD (R01 DC020737, R01DC020302)
This publication has 64 references indexed in Scilit:
- Oral somatosensory alterations and salivary dysfunction in head and neck cancer patientsSupportive Care in Cancer, 2023
- Acute Taste Dysfunction in Oropharyngeal Cancer Patients after Transoral Robotic SurgeryThe Laryngoscope, 2023
- Performance, Usability, and User Experience of Rayyan for Systematic ReviewsProceedings of the Association for Information Science and Technology, 2022
- Prospective Evaluation of Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated RadiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2022
- Transitioning the eating experience in survivors of head and neck cancerSupportive Care in Cancer, 2021
- Nutrition Status and Health‐Related Quality of Life Among Outpatients With Advanced Head and Neck CancerNutrition in Clinical Practice, 2020
- Oral examination findings, taste and smell testing during and following head and neck cancer therapySupportive Care in Cancer, 2020
- Olfactory and gustatory functions after free flap reconstruction and radiotherapy for oral and pharyngeal cancer: a prospective follow-up studyEuropean Archives of Oto-Rhino-Laryngology, 2018
- Liposomal treatment of xerostomia, odor, and taste abnormalities in patients with head and neck cancerHead & Neck, 2015
- Oral symptoms and functional outcome related to oral and oropharyngeal cancerSupportive Care in Cancer, 2010